2021 west oncology | lung cancer | egfr mutation therapy resistance and adcs and trop2
Published 3 years ago • 2K plays • Length 20:34Download video MP4
Download video MP3
Similar videos
-
3:44
what is a driver mutation?
-
18:23
2021 west oncology | lung cancer | targeted therapies
-
26:35
2021 west oncology app | lung cancer treatments update
-
33:54
2021 west oncology | lung cancer | panel discussion and q&a
-
2:23
therapeutic strategies for egfr-mutated lung cancer
-
1:00:28
2021 evolution | lung cancer case presentation
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
27:21
2022 west oncology conference | lung cancers | q&a and panel discussion
-
59:36
ilcn multidisciplinary forum: understanding treatment options and resistance in egfr-positive nsclc
-
14:24
egfr-mutant lung cancer & treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
1:17:52
egfr initial treatment, acquired resistance and q&a with h. jack west, md and helena yu, md
-
1:41
egfr mutations in patients with lung cancer
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
4:51
understanding egfr-mutant nsclc subsets
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
1:05:12
new horizons in egfr-mutated nsclc: broadening the impact of precision testing
-
1:11
dr. gitlitz on egfr exon 20 insertion mutations in lung cancer